Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Best Foreign Dividend Stocks To Invest In

In this article, we discuss 5 best foreign dividend stocks to invest in. If you want to read our detailed analysis of the performance of dividend stocks over the years, go directly to read 12 Best Foreign Dividend Stocks To Invest In

5. Canadian Natural Resources Ltd (NYSE:CNQ)

Number of Hedge Fund Holders: 41

Canadian Natural Resources Ltd (NYSE:CNQ) is one of the largest independent crude oil and natural gas exploration, development, and production companies in Canada. In November 2023, the company declared an 11% hike in its quarterly dividend to C$1.00 per share. This marked the company’s 25th consecutive year of dividend growth, which makes CNQ one of the best foreign dividend stocks. The stock has a dividend yield of 4.57%, as of January 26.

The number of hedge funds tracked by Insider Monkey owning stakes in Canadian Natural Resources Ltd (NYSE:CNQ) jumped to 41 in Q3 2023, from 36 in the previous quarter. The consolidated value of these stakes is roughly $3 billion. Among these hedge funds, GQG Partners was the company’s leading stakeholder in Q3.

Follow Canadian Natural Resources Ltd (NYSE:CNQ)

4. AstraZeneca plc (NASDAQ:AZN)

Number of Hedge Fund Holders: 49

AstraZeneca plc (NASDAQ:AZN) is a Cambridge-based global biopharmaceutical company that engages in the research, development, manufacturing, and marketing of prescription medications. The company pays an interim dividend of $0.93 per share and has a dividend yield of 2.21%, as of January 26.

Insider Monkey’s database of Q3 2023 indicated that 49 hedge funds owned stakes in AstraZeneca plc (NASDAQ:AZN), up from 41 in the preceding quarter. The total value of stakes owned by these hedge funds is over $2.64 billion.

ClearBridge Investments mentioned AstraZeneca plc (NASDAQ:AZN) in its Q4 2023 investor letter. Here is what the firm has to say:

“In the second half of 2023 — as we were selling low-growth, high-multiple stocks and taking advantage of oversold conditions in infrastructure, real estate and utilities — we also found opportunities in overlooked areas of health care. After adding Gilead in the third quarter, we bought AstraZeneca PLC (NASDAQ:AZN) in the fourth quarter. Each of these stocks present distinct investment cases, but both are reasonably valued and have limited patent expiry or pipeline risk. Gilead’s strength comes from its dominant franchise in HIV. It offers lower growth, but it yields nearly 4% and trades at 11x earnings. AstraZeneca possesses a diversified portfolio of pharmaceuticals, which should deliver double-digit earnings growth, yet it trades at just 16x earnings. These stocks were underwritten individually, but collectively we like the idea of increasing our exposure to defensive and growing health care names at below-market multiples.”

Follow Astrazeneca Plc (NYSE:AZN)

3. Shell plc (NYSE:SHEL)

Number of Hedge Fund Holders: 49

Shell plc (NYSE:SHEL) ranks third on our list of the best foreign dividend stocks. It is one of the largest integrated energy companies globally. It operates in various segments of the energy industry, including upstream exploration and production, downstream refining and marketing, and integrated gas. The company offers a quarterly dividend of $0.662 per ADS and has a dividend yield of 4.09%, as of January 26.

At the end of Q3 2023, 49 hedge funds reported having stakes in Shell plc (NYSE:SHEL), up from 43 in the preceding quarter, as per Insider Monkey’s database. These stakes are collectively valued at over $3.26 billion.

Follow Shell Plc (NYSE:SHEL)

2. ASML Holding N.V. (NASDAQ:ASML)

Number of Hedge Fund Holders: 57

ASML Holding N.V. (NASDAQ:ASML) is a Dutch company that specializes in the design and manufacturing of photolithography equipment used in the semiconductor manufacturing process. On January 24, the company declared an interim dividend of €1.45 per share, which was in line with its previous dividend. It is one of the best foreign dividend stocks on our list as the company has been paying regular dividends to shareholders since 2013. The stock has a dividend yield of 0.76%, as of January 26.

The number of hedge funds tracked by Insider Monkey owning stakes in ASML Holding N.V. (NASDAQ:ASML) grew to 57 in Q3 2023, from 55 in the previous quarter. The total value of these stakes is over $6.08 billion. Among these hedge funds, Fisher Asset Management was the company’s leading stakeholder in Q3.

Follow A S M L Holding N V (NASDAQ:ASML)

1. Linde plc (NYSE:LIN)

Number of Hedge Fund Holders: 71

With 71 hedge fund positions at the end of Q3 2023, Linde plc (NYSE:LIN) tops our list of the best foreign dividend stocks. The total stakes owned by these hedge funds in the multinational industrial gases and engineering company amounted to roughly $4 billion, according to Insider Monkey’s database.

Linde plc (NYSE:LIN) has been growing its dividends for the past 28 consecutive years and currently pays a quarterly dividend of $1.275 per share. The stock’s dividend yield on January 27 came in at 1.26%.

Follow Linde Plc (NASDAQ:LIN)

You can also take a look at 10 Dividend Stocks with Sustainable Payout Ratios and 13 Most Buzzing Stocks To Buy Now

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.